Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

Maureen O'Brien, MD, Gary Dahl, MD, Stanley Pounds, Norman J. Lacayo, MD, Jeffrey Taub, MD, Myron Chang, Howard J. Weinstein, MD, Yaddanapudi Ravindranath, MBBS, Dario Campana, MD, PhD, Ching-Hon Pui, MD, Jeffrey Rubnitz, MD, PhD

Blood (2009) 114 (22): 482.

https://doi.org/10.1182/blood.V114.22.482.482

Published: 2009

Journal Articles

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Minnie Abromowitch, MD, Amanda Termuhlen, MD, Myron Chang, PhD, Sherrie L. Perkins, MD, PhD, Thomas Gross, MD, PhD, Howard J. Weinstein, MD, Jonathan Finlay, MD

Blood (2008) 112 (11): 3610.

https://doi.org/10.1182/blood.V112.11.3610.3610

Published: 2008

Journal Articles

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman J. Lacayo, MD, Maureen O’Brien, MD, Shweta Jain, Soheil Meshinchi, MD, PhD, Ron Yu, PhD, Dejan Juric, MD, Myron N. Chang, PhD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD

Blood (2006) 108 (11): 1915.

https://doi.org/10.1182/blood.V108.11.1915.1915

Published: 2006

Journal Articles

Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.

Jacob M. Rowe, MD, Xiaochun Li, Peter A. Cassileth, MD, Frederick R. Appelbaum, MD, Charles A. Schiffer, MD, Peter H. Wiernik, MD, Mark R. Litzow, MD, Larry D. Cripe, MD, Hillard M. Lazarus, MD, Elisabeth Paietta, Ph.D, Gordon W. Dewald, MD, Howard J. Weinstein, MD, Angela K. Ogden, MD, William G. Woods, MD, Lois Shepherd, MD, James H. Feusner, MD, Clara D. Bloomfield, MD, Martin S. Tallman, MD

Blood (2005) 106 (11): 546.

https://doi.org/10.1182/blood.V106.11.546.546

Published: 2005

Journal Articles

Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children’s Oncology Group (COG) Study POG #9421.

Dennis J. Kuo, MD, Norman J. Lacayo, MD, Don Hoang, Dejan Juric, MD, Susana C. Raimondi, PhD, David Chen, Myron N. Chang, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD

Blood (2005) 106 (11): 2771.

https://doi.org/10.1182/blood.V106.11.2771.2771

Published: 2005

NARROW

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.

Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children’s Oncology Group (COG) Study POG #9421.

Email alerts

ASH Publications

American Society of Hematology

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.

Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children’s Oncology Group (COG) Study POG #9421.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only